| Income statement (USD) | FY 2025 ended Dec 31, 2025 | FY 2024 ended Dec 31, 2024 | FY 2023 ended Dec 31, 2023 | FY 2021 ended Dec 31, 2022 | FY 2021 ended Dec 31, 2021 | FY 2020 ended Dec 31, 2020 |
|---|---|---|---|---|---|---|
| Revenue | 5.14B | 5.38B | 9.62B | 7.32B | 3.33B | 3.13B |
| Cost of revenue | 4.47B | 5.31B | 8.43B | 4.25B | 2.33B | 2.13B |
| Gross profit | 668.72M | 62.54M | 1.19B | 3.07B | 997.97M | 994.85M |
| Research and development | 51.40M | 86.72M | 85.72M | 71.98M | 54.03M | 59.21M |
| Selling, general and admin | 550.04M | 618.05M | 910.00M | 524.14M | 441.48M | 429.83M |
| Operating income | -367.08M | -1.78B | 251.88M | 2.47B | 798.43M | 505.81M |
| EBITDA | 291.59M | -1.19B | 681.83M | 2.77B | 1.05B | 737.80M |
| Income before tax | -552.07M | -1.76B | 246.74M | 2.43B | 133.62M | 373.52M |
| Income tax | 156.88M | 87.08M | 430.28M | 390.59M | 29.45M | 54.42M |
| Net income | -510.63M | -1.18B | 1.57B | 2.69B | 123.67M | 375.76M |
| EPS | -5.76 | -11.20 | 13.41 | 22.97 | 1.07 | 3.53 |
| EPS (diluted) | -5.76 | -11.20 | 13.36 | 22.84 | 1.06 | 3.52 |
| Diluted shares | 117.66M | 117.52M | 117.77M | 117.79M | 116.54M | 106.81M |
| Dividends per share | 1.62 | 1.61 | 1.60 | 1.58 | 1.56 | 1.54 |
From Albemarle's 10-K and 10-Q filings with the SEC. Fiscal years are the company's own, so they may not match the calendar. A blank cell means the company did not report that line. New to this? Read income statement or reading a 10-K.
Revenue, earnings, margins and balance sheet trends drawn by TradingView from its own data, so figures can differ slightly from the SEC table above.